BOJI CRO: "TBA Tablets" drug clinical trial approved
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, BOJI CRO announced that the "TBA tablet" developed in collaboration with Guangdong Gumaidi Health Technology Co., Ltd. has received the "Notice of Approval for Drug Clinical Trials" issued by the National Medical Products Administration. TBA is a new, structurally defined compound with pharmacological effects and clinical value, classified as a Category 1 innovative drug that has not been marketed domestically or internationally, with the intended indication being drug-resistant pulmonary tuberculosis
According to the Zhitong Finance APP, BOJI CRO (300404.SZ) announced that the "TBA tablet" developed in collaboration with Guangdong Gumaidi Health Technology Co., Ltd. has received the "Drug Clinical Trial Approval Notification" issued by the National Medical Products Administration. TBA is a new compound with a clear structure and pharmacological effects, and it has clinical value. It is a Class 1 innovative drug that has not been marketed domestically or internationally, with the intended indication being drug-resistant pulmonary tuberculosis